SCHEMBL29617733

SCHEMBL29617733

Nc1ncnc2c1cnn2C1CCCC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.59
BTK Q06187 2/20 0.59
PI4KB Q9UBF8 6/20 0.51
PI4KA P42356 5/20 0.51
PI4K2B Q8TCG2 5/20 0.51
PI4K2A Q9BTU6 5/20 0.51
ADORA2A P29274 5/20 0.49
ADORA3 P0DMS8 4/20 0.49
ADORA1 P30542 4/20 0.49
ABL1 P00519 4/20 0.47
BCR P11274 2/20 0.47
SIGMAR1 Q99720 1/20 0.47
SLC2A1 P11166 1/20 0.46
SLC2A2 P11168 1/20 0.46
SLC2A3 P11169 1/20 0.46
DAPK3 O43293 2/20 0.46
MAP4K4 O95819 2/20 0.46
PAK4 O96013 2/20 0.46
LCK P06239 2/20 0.46
FYN P06241 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19362509 1.00 EGFR (0.59) EGFRBTKPI4KBPI4KAPI4K2B
SCHEMBL19463908 0.98 EGFR (0.58) EGFRBTKPI4KBPI4KAPI4K2B
SCHEMBL31037237 0.98 EGFR (0.58) EGFRBTKPI4KBPI4KAPI4K2B
SCHEMBL21807058 0.97 EGFR (0.59) EGFRBTKPI4KBPI4KAPI4K2B
SCHEMBL20744975 0.93 EGFR (0.55) EGFRBTKPI4KBPI4KAPI4K2B
SCHEMBL30041613 0.93 EGFR (0.55) EGFRBTKPI4KBPI4KAPI4K2B
SCHEMBL1501671 0.86 EGFR (0.50) EGFRBTKPI4KBPI4KAPI4K2B
SCHEMBL29886844 0.86 EGFR (0.50) EGFRBTKPI4KBPI4KAPI4K2B
Hydrochloric Acid SCHEMBL1501585 0.85 EGFR (0.49) EGFRBTKPI4KBPI4KAPI4K2B
SCHEMBL13762806 0.85 PI4KA (0.54) EGFRBTKPI4KBPI4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114685516-A Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-07-01 CN disclosed
CN-108431007-B Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-06-07 CN disclosed